Clinical and Translational Radiation Oncology

Article	Citations
The technical design and concept of a PET/CT linac for biology-guided radiotherapy	36
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator	26
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry	23
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer	23
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance	23
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience	20
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients	19
CDK 4/6 inhibitors combined with radiotherapy: A review of literature	19
Radiomic biomarkers of tumor immune biology and immunotherapy response	18
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients	17
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy	16
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a	16
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)	16
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy	15
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth	14
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma	13
The changing role of radiation oncology professionals in a world of AI – Just jobs lost – Or a solution to the under-provision of radiotherapy?	12
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center cli	12
X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom	12
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer	11
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation	11
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	11
Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors	10
MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases	10
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator	10

GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer	10
Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume	10
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer	9
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review	9
Breast cancer radiation therapy: A bibliometric analysis of the scientific literature	9
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer	9
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac	9
Lattice Radiation Therapy in clinical practice: A systematic review	9
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer	8
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer	8
Large anatomical changes in head-and-neck cancers – A dosimetric comparison of online and offline adaptive proton therapy	8
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study	8
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database	8
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gas	8
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma	8
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma	8
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial	8
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy	8
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology	8
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma	7
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis	7
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab	7
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	7
A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS	7
European radiation oncology after one year of COVID-19 pandemic	7
Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study	7
Cardiac radioablation in the treatment of ventricular tachycardia	7
Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up	7
The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A syst	7
Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network	7
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey	7
Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018	7
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer	6
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	6
Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer	6
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	6
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	6
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	6
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation	6
Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer	6
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group	6
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy	6
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise	6
Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality	6
Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients	6
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework	6
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation	6
Voluntary versus ABC breath-hold in the context of VMAT for breast and locoregional lymph node radiotherapy including the internal mammary chain	6
Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life	6
Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis	6

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes	6
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	5
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	5
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review	5
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial	5
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study	5
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly	5
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre	5
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis	5
Proton therapy of a pregnant patient with nasopharyngeal carcinoma	5
Artificial intelligence to predict outcomes of head and neck radiotherapy	5
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)	5
Adaptive radiotherapy for breast cancer	4
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adap	4
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study	4
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	4
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer	4
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	4
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer	4
Impact of transitioning to an online course – A report from the ESTRO gyn teaching course	4
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis	4
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?	4
Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?	4
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk	4
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)	4
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre	4
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma	4
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	4
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control	4
Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study	4
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids	4
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	4
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	4
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution	4
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	4
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal	4
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk	4
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence	4
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale	4
The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas	4
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies	4
Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer	4
Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation	4
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients	4
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis	4
The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry	3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	3
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	3
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	3
Radiation therapy for primary orbital and ocular adnexal lymphoma	3
Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar	3
Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature	3
Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma	3
Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRI	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?	3
Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis	3
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	3
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	3
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	3
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer	3
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis	3
Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma	3
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	3
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey	3
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?	3
Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma	3
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience	3
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer	3
Inhalation anesthesia and shielding devices to allow accurate preclinical irradiation of mice with clinical linac-based systems: Design and dosimetric characteristics	3
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis	3
Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer	3
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial	3
AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN	3
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	3
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience	3

A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer	2
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule	2
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset	2
Statistical fundamentals on cancer research for clinicians: Working with your statisticians	2
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	2
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	2
Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data	2
PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation	2
Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)	2
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis	2
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis	2
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer	2
Feasibility of biology-guided radiotherapy for metastatic renal cell carcinoma driven by PSMA PET imaging	2
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors	2
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial	2
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer	2
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	2
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastases	2
Exploring breast and prostate cancer RNA-seq derived radiosensitivity with the Genomic Adjusted Radiation Dose (GARD) model	2
Stereotactic lung reirradiation for local relapse: A case series	2
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterizat	2
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”	2
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma	2
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	2
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial	2
Proton beam therapy for a giant hepatic hemangioma: A case report and literature review	2
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT	2
A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry	2
Thyroid volume changes following adjuvant radiation therapy for breast cancer	2
Prophylactic cranial irradiation for extensive-stage small cell lung cancer: Analysis based on active brain MRI surveillance	2
Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature	2
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	2
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	2
Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study	2
Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors	2
Irradiation of localized prostate cancer in the elderly: A systematic literature review	2
Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience	2
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study	2
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol	2
Patients’ needs in proton therapy: A survey among ten European facilities	2
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	2
Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio	2
Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports	2
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain	2
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group	2
Overall survival nomogram for patients with spinal bone metastases (SBM)	2
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy	2
Long-term follow up of a patient with a recurrent desmoid tumor that was successfully treated with proton beam therapy: A case report and literature review	2
A time-resolved clonogenic assay for improved cell survival and RBE measurements	2
Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1	2
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	2
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)	2
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	2
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease	2
Dosimetric impact of adaptive proton therapy in head and neck cancer – A review	2
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	2
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	2
Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)	2
Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours	2
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	2
Tomotherapy for cranio-spinal irradiation	2
BRIDGE −1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial	2
Benchmarking machine learning approaches to predict radiation-induced toxicities in lung cancer patients	2
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey	2
Stereotactic radiosurgery (SRS) – A new normal for small cell lung cancer?	2
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy	1
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer	1
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	1
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	1
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges	1
External validation of Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radi	1
Extramedullary hematopoiesis causing spinal cord compression in polycythemia vera: A case report and literature review	1
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	1
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome	1
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity	1
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer	1
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	1
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	1
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”	1
#radonc: Growth of the global radiation oncology Twitter network	1
Application and progress of artificial intelligence in radiation therapy dose prediction	1
Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer	1
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	1
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial	1
Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer	1
The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy	1
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma	1
Do We Have a Winner? Advocating for SBRT in HCC Management	1
The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment	1
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	1
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis	1
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature	1
A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry	1
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter ret	1